Page last updated: 2024-08-24

methylcyclopentadiene and Colorectal Cancer

methylcyclopentadiene has been researched along with Colorectal Cancer in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avecilla, F; Brás, AR; Côrte-Real, L; Garcia, MH; Haukka, M; Moreira, T; Preto, A; Robalo, MP; Sanches, A; Tatikonda, R; Teixeira, RG; Valente, A1

Other Studies

1 other study(ies) available for methylcyclopentadiene and Colorectal Cancer

ArticleYear
Novel ruthenium methylcyclopentadienyl complex bearing a bipyridine perfluorinated ligand shows strong activity towards colorectal cancer cells.
    European journal of medicinal chemistry, 2018, Jan-01, Volume: 143

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Cycloparaffins; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Ligands; Molecular Structure; Organometallic Compounds; Pyridines; Ruthenium; Structure-Activity Relationship

2018